Harrow, Inc. announced Q1 2026 revenue of $44.2 million, impacted by an $8 million adjustment related to new VEVYE commercial coverage. Despite an 18% decline in the branded dry eye market, VEVYE prescriptions hit record levels, surpassing competitor XIIDRA and driving strong demand growth. Other products, IHEEZO and TRIESENCE, also showed significant year-over-year demand increases. The company reaffirmed its 2026 revenue guidance of $350 million to $365 million and expects Q2 revenue between $71 million and $81 million, signaling confidence in continued growth and expanded commercial access.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
Ethereum's price rose about 11% over the past week to around $1,920, outperforming major cryptocurrencies like Bitcoin and Solana. This rally is fueled by $96 million inflows into U.S. spot Ether ETFs early in the week, with BlackRock's ETHA product ...
The XRP Ledger has surpassed 8 million activated accounts, marking steady growth since March 2026. However, daily active addresses have declined to a 2026 low of 25,350, indicating less frequent user engagement despite overall adoption. XRP's price f...
